key: cord-0695094-sahmmwpr
authors: Sharma, Aditya Prakash; Sahoo, Swapnajeet; Goyal, Kapil; Chandna, Abhishek; Kirubanandhan, Sangeetha; Sharma, Vikrant; Grover, Sandeep; Singh, Mini P.; Bhalla, Ashish; Singh, Shrawan K.
title: Absence of SARS‐CoV‐2 infection in the semen of men recovering from COVID‐19 infection: An exploratory study and review of literature
date: 2021-06-11
journal: Andrologia
DOI: 10.1111/and.14136
sha: 6e537e5a7193b728c5b1a27adb3a98626ba4d8a2
doc_id: 695094
cord_uid: sahmmwpr

The effect of COVID‐19 on the male reproductive tract has been sparsely studied. This exploratory study was designed to determine the presence of SARS‐CoV‐2 in the semen of men recovering from COVID‐19. A systematic literature review was also performed as per PRISMA guidelines to gather perspective on this topic. The prospective study included men 21 years and older recovering from COVID‐19 with nasopharyngeal swab negative for SARS‐CoV‐2 or at least two weeks from the last COVID RT‐PCR positivity. After clinical evaluation, freshly ejaculated semen sample by masturbation was collected in a sterile container. Samples were processed for the detection of SARS‐CoV‐2 by RT‐PCR. Twenty‐one patients were contacted for the study, 11 of which consented to provide a semen sample. The mean age of the cohort was 29.72 ± 4.52 years. None of the patients gave a history of epididymo‐orchitis or sexual dysfunction at the time of assessment. None of the semen samples demonstrated SARS‐CoV‐2 on RT‐PCR. Median duration of semen sample collection from the COVID positivity was 44 days (Range 19–59 days). Detailed literature review revealed that SARS‐CoV‐2 is not found in patients recovering from COVID‐19 infection. We conclude that SARS‐CoV‐2 is not found in the semen of patients recovering from COVID‐19.

SARS-CoV-2 in testicular tissue, and there have been reports of loss of testicular architecture in patients with COVID-19 infection (Achua et al., 2021; Vishvkarma & Rajender, 2020) . A recent review (Huang et al., 2021) has suggested cytopathic effects in testes due to virus and indirect damage due to immunopathological reaction as potential reasons for the development of infertility in patients with SARS-CoV-2 patients. These studies have also called into question the presence of this virus in semen and its transmissibility via sexual intercourse.

A limited number of studies have explored this intriguing aspect of SARS-CoV-2 infection. Song et al. (2020) found no evidence of this virus in the semen of 12 patients recovering from COVID-19. Another study (Pan et al., 2020) semen. On the other hand, a recent study failed to demonstrate SARS-CoV-2 in the semen of 16 active patients using RT-PCR (Kayaaslan et al., 2020) .

From the current evidence, the presence of SARS-CoV-2 in semen and its impact on the reproductive health of men recovering from COVID-19 remains controversial at best (Achua et al., 2021; Kayaaslan et al., 2020; Li et al., 2020; Ma et al., 2021; Song et al., 2020) . Hallak et al. (2021) highlighted the lack of precise methodology on collection and interpretation of RT-PCR, and the absence of data on viral load poses a significant challenge in the validation of these results by other groups. Hence, we designed this study to determine the presence of SARS-CoV-2 in semen in our subpopulation recovering from COVID-19 to rectify these methodological flaws and shed some more light on this topic. We also performed a systematic literature review and compared all the available literature on this topic.

This prospective observational study was conducted at the Departments of Urology Virology and Psychiatry, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh.

The institutional ethics committee approval was obtained for the study (NK/6304/Study/095). Men recovering from COVID-19 and aged 21 years or more, with a nasopharyngeal swab negative for SARS-CoV-2 or at least 2 weeks from the last COVID RT-PCR positivity were included in the study. Patients were classified as mild if they had low-grade fever, cough, malaise, rhinorrhea and sore throat without shortness of breath. They were classified as moderate if they required admission due to a respiratory rate of >30/min and/or oxygen saturation (SpO2)<93% on room air.

The patients' details were recorded on a proforma, and a history suggestive of epididymo-orchitis was enquired from all the patients. Additionally, all the patients were evaluated for any sexual dysfunction by a thorough psychosexual history and examination.

The external genitalia and testis were examined for any telltale sign of epididymo-orchitis. Testicular volume was measured using Prader's orchidometer. A freshly ejaculated semen sample was collected in a sterile container by masturbation. The patient was asked to use all precautionary measures to avoid contamination, such as thorough cleaning of hands and genitals before providing the sample.

The samples were transported to the Department of Virology, ensuring a proper cold chain, and were processed to detect SARS-CoV-2 using real-time PCR by taking adequate biosafety 

Literature review was performed in consistent with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (90.9%) patients had fever as the presenting complaint, among which 6 (54.6%) patients had associated cough. One patient (9.1%) presented with nasal stuffiness alone. The cycle threshold (Ct) values ranged from 20 to 33 (Table 1) subsequently, the documentation of RT-PCR negativity became nonmandatory for mild to moderate disease (due to incorporation of home isolation policy); hence, the date of negative report documentation is not available in later cases.

A total of 13 articles studying the presence of SARS-CoV-2 in semen were included for the final analysis (Table 2, Figure 3 ). Table 2 

Only two studies Machado et al., 2021) 

11/13 studies showed that no SARS-CoV-2 could be detected in semen ( Table 2 ). The number of patients enrolled in these studies ranged from 1 to 70, and the median duration after which the first sample was taken ranged from 0 days to 80 days.

As seen from the bubble plot, four studies have performed RT-PCR in semen in <21 days. Among them, only 2 studies found a total of 7 patients positive, and the rest all were negative. None of the studies beyond the period of 21 days has shown the presence of SARS-CoV-2 in semen.

Apart from respiratory droplets and contact surfaces, the SARS-CoV-2 has been detected in the infected patients' blood, saliva and urine . Its entry is mediated by ACE2 receptors, which have been expressed in several organs in the human body, including the male reproductive tract (Hoffmann et al., 2020; Wang et al., 2020) . Although recent studies have found no evidence of sexual transmission of SARS-CoV-2 (Kayaaslan et al., 2020; Ma et al., 2021; Pan et al., 2020; Song et al., 2020) , its impact on the male reproductive tract and detection in semen remains controversial with only two studies showing RT-PCR positivity in semen Machado et al., 2020) .

We conducted this prospective study on patients who had recovered from COVID-19 infection for further insight in our subpopulation. Out of 21 patients contacted, 13 patients consented to the examination of the external genitalia that was normal in all the patients. The Ct values in Table 1 reflect that all but one patient had high viral load at the time of initial infection. Eleven patients agreed to provide a masturbatory semen sample for RT-PCR; however, none of them showed the presence of SARS-CoV-2 in semen.

For the initial four patients, the subsequent nasopharyngeal swab SARS CoV-2 negative report was also available. It can be seen that Figure 3 ).

Moreover, one study (Kayaaslan et al., 2020) failed to demonstrate SARS-CoV-2 in the semen of active patients as well using RT-PCR.

Their timeline in these studies for recruiting the earliest patient ranged between 0 and 8 days from nasopharyngeal positivity. It could also be possible that acute viraemia/viral load was different in these sub-populations. In our study, the median duration was 44 days with a moderate to high initial viral load (20 to 33) in the nasopharyngeal swab (Table 1) . The bubbles plot also shows 4/13 studies testing semen within three weeks of diagnosis of COVID-19, and all the studies beyond 20 days failed to indicate the presence of SARS-CoV-2 in semen.

From our study and analysis of available literature cited in Table 2 , it is possible to suggest that SARS-CoV-2 RNA may not be detectable in semen well after convalescence (>21 days). Even with evidence in favour of the presence of SARS-CoV-2 in semen in the acute phase in two studies , there was no evidence of the persistence of the virus in ejaculate in the convalescence phase of the disease in any of the studies. Based on the available literature, the Italian Society of Andrology in August 2020 had stated that the available data do not support the presence of SARS-CoV-2 in semen (Corona et al., 2020) . This came as a relief to all the clinicians involved with assisted reproduction as most of the ART programs were initially hit by the fear of transmission of COVID-19 through semen. Moreover, whether the presence of RNA (using RT-PCR) in the semen of clinically recovered patients implies transmissibility of infection or detection of noninfectious viral fragments can be answered only by the growth of viable virus particles on viral cultures from semen.

The impact of viral illness on reproductive health is always a matter of concern. Although the presence of ACE-2 receptors on the testis has been cited as a potential source of infection of the testis by SARS-CoV-2, the evidence regarding the COVID-19 affliction of testis directly is controversial. Presently, the affliction of testis could be attributed to an indirect immune-mediated reaction, as established by the autopsy studies Teixeira et al., 2021) . The COVID-19 pandemic also hit the assisted reproduction facilities due to uncertainties over the transmission of virus through semen and its effect on embryo and pregnancy.

As discussed earlier, researchers have postulated that the chances of presence of virus in the semen are minuscule (Singh, 2020) , and thus, the concerns to utilisation of spermatozoa for assisted reproduction should also be alleviated.

CoV-2 to the foetus has also been a matter of concern. The absence of ACE-2 in vaginal epithelial cells (Qiu et al., 2020) substantiates this hypothesis, and transmission through heterosexual penetrative intercourse alone seems less likely. However, we still feel intercourse during active illness and early convalescence should be avoided; masturbation is best suited during this period.

In conjunction with available literature, our study establishes that a carrier state in COVID-19 in semen is nonexistent, and the detection of SARS-CoV-2 in semen beyond 21 days is not present. Thus, it is safe to say that heterosexual transmission is highly unlikely after 3-4 weeks from the nasopharyngeal positivity with the above considerations. This study also paves the way for utilisation of ejaculated spermatozoa for assisted reproduction in patients recovering from COVID-19 illness.

To the best of our knowledge, this is the first prospective study on the presence of SARS-CoV-2 in semen from India with an exhaustive literature review on the topic. The limitation of this study remains a small sample size and unable to recruit patients with acute infection or early convalescence. Another limitation was the inability to document a negative COVID status on nasopharyngeal swab due to change in national guidelines as mentioned. However, the study does contribute and consolidates the guidelines for safe sex practices in patients recovering from COVID-19 infection.

SARS-CoV-2 is not found in the semen of patients recovering from COVID-19. Transmission through semen and establishment of carrier state is unlikely after the convalescent phase.

Histopathology and ultrastructural findings of fatal COVID-19 infections on testis

An evaluation of semen parameters in men with confirmed covid-19 infection

TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells

SARS-CoV-2 infection, male fertility and sperm cryopreservation: A position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Società Italiana di Andrologia e Medicina della Sessualità)

Absence of SARS-CoV-2 in semen of a COVID-19 patient cohort

SARS-CoV-2 and its relationship with the genitourinary tract: Implications for male reproductive health

Assessment of SARS-CoV-2 in human semen-a cohort study

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Coronavirus: A possible cause of reduced male fertility

Zika virus in semen: A prospective cohort study of symptomatic travellers returning to Belgium

Coronavirus Disease (COVID-19) Dashboard. (n.d.). Retrieved

Vertical transmission of coronavirus disease 19 (COVID-19) from infected pregnant mothers to neonates: A review

Investigation of SARS-CoV-2 in semen of patients in the acute stage of COVID-19 infection

Clinical characteristics and results of semen tests among men with coronavirus disease 2019

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients

Presence of SARS-CoV-2 RNA in semen-cohort study in the United States COVID-19 positive patients

No evidence of SARS-CoV-2 in semen of males recovering from COVID-19

Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive nasopharyngeal swab

SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection

No evidence of SARS-CoV-2 seminal shedding despite SARS-CoV-2 persistence in the upper respiratory tract

No detection of SARS-CoV-2 from urine, expressed prostatic secretions, and semen in 74 recovered COVID-19 male patients: A perspective and urogenital evaluation

Is SARS-CoV-2 vertically transmitted? Frontiers in Pediatrics

Assisted reproduction in COVID-19 season: Expend the fear

Absence of 2019 novel coronavirus in semen and testes of COVID-19 patients

Viral infections and implications for male reproductive health

Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: A cross-sectional, pilot study

Could SARS-CoV-2 affect male fertility?

Detection of SARS-CoV-2 in different types of clinical specimens

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

A pneumonia outbreak associated with a new coronavirus of probable bat origin